DHEA-S: What This Test Actually Measures

What DHEA-S Is and Why It Matters

DHEA-S (dehydroepiandrosterone sulfate) is the sulfated, water-soluble storage form of DHEA. Your adrenal glands produce roughly 6-8 mg of DHEA daily, and the vast majority circulates as DHEA-S after sulfation in the adrenal cortex and liver [1]. No other steroid reaches comparable concentrations in the bloodstream.

The distinction between DHEA and DHEA-S is clinically meaningful. DHEA itself has a short half-life of 15-30 minutes, fluctuates throughout the day, and is produced by both the adrenals and the gonads. DHEA-S, by contrast, has a half-life of 10-20 hours and shows almost no diurnal variation [2]. That stability makes DHEA-S the preferred laboratory marker for adrenal androgen output. A single morning blood draw gives a reliable snapshot without the timing constraints that complicate cortisol testing.

DHEA-S functions as a prohormone. It does not bind androgen or estrogen receptors directly. Peripheral tissues, including skin, fat, bone, and the reproductive organs, express the enzymes steroid sulfatase and 3-beta-hydroxysteroid dehydrogenase that convert DHEA-S into active androgens (testosterone, dihydrotestosterone) and estrogens (estradiol, estrone) [3]. This process, called intracrinology, means that local tissue concentrations of sex steroids can be high even when serum testosterone or estradiol appear normal.

The Endocrine Society has identified DHEA-S as a reliable marker of adrenal androgen secretion and recommends it in the workup of androgen excess disorders, particularly in women presenting with hirsutism, acne, or virilization [4].

How the Adrenal Glands Produce DHEA-S

The zona reticularis of the adrenal cortex is responsible for nearly all DHEA-S synthesis. This innermost adrenal layer develops fully during adrenarche, the period between ages 6 and 8 when adrenal androgen production begins rising well before puberty [5]. ACTH (adrenocorticotropic hormone) from the pituitary gland drives production, though the relationship is not as tightly coupled as the ACTH-cortisol axis.

Synthesis follows the classic steroidogenic pathway. Cholesterol enters the mitochondria via the StAR protein. Cytochrome P450scc cleaves the side chain to produce pregnenolone. CYP17A1 then hydroxylates and lyases pregnenolone into DHEA, which the sulfotransferase enzyme SULT2A1 converts to DHEA-S [6]. A key point: the zona reticularis expresses high levels of CYP17A1 lyase activity but low levels of 3-beta-HSD, which is why it preferentially produces DHEA rather than cortisol.

Small amounts of DHEA also come from the ovaries and testes. But gonadal contribution to circulating DHEA-S is minor, typically under 5-10%. That is why DHEA-S is considered adrenal-specific. After bilateral adrenalectomy, DHEA-S levels drop to near zero [1].

Normal DHEA-S Ranges by Age and Sex

DHEA-S is one of the most age-sensitive biomarkers in clinical medicine. Levels follow a distinctive arc: low in childhood, rapidly rising during adrenarche, peaking between ages 20 and 30, then declining steadily for the rest of life. By age 70-80, DHEA-S concentrations are typically 10-20% of their peak values [7].

The 2017 Endocrine Society clinical practice guideline on hirsutism references DHEA-S as part of the standard androgen panel and notes that laboratory-specific reference ranges should be used [4]. General adult reference intervals from major clinical laboratories (expressed in mcg/dL) are as follows:

Women:

• Age 18-29: 65-380 mcg/dL
• Age 30-39: 45-270 mcg/dL
• Age 40-49: 32-240 mcg/dL
• Age 50-59: 26-200 mcg/dL
• Age 60-69: 13-130 mcg/dL
• Age 70+: 17-90 mcg/dL

Men:

• Age 18-29: 108-540 mcg/dL
• Age 30-39: 120-520 mcg/dL
• Age 40-49: 95-530 mcg/dL
• Age 50-59: 70-310 mcg/dL
• Age 60-69: 42-290 mcg/dL
• Age 70+: 28-175 mcg/dL

These ranges vary between assays. Immunoassay and liquid chromatography-tandem mass spectrometry (LC-MS/MS) can yield different absolute values, so comparing results across laboratories requires caution [8]. The age-related decline, sometimes called "adrenopause," has prompted research into whether DHEA supplementation can slow aging. The results, as discussed below, have been mixed.

What High DHEA-S Levels Indicate

An elevated DHEA-S signals excessive adrenal androgen production. The clinical significance depends on the degree of elevation, the patient's sex, and accompanying symptoms.

Polycystic ovary syndrome (PCOS) is the most common cause of mildly elevated DHEA-S in premenopausal women. Roughly 20-30% of women with PCOS have elevated DHEA-S, even when ovarian androgens are the primary driver [9]. The 2023 international evidence-based guideline for PCOS assessment lists DHEA-S among the androgens that may be measured when evaluating biochemical hyperandrogenism, alongside total testosterone and free testosterone [10].

Congenital adrenal hyperplasia (CAH), particularly the non-classic form caused by 21-hydroxylase deficiency, can present with elevated DHEA-S in combination with elevated 17-hydroxyprogesterone. The Endocrine Society's 2018 CAH guideline recommends screening with an early-morning 17-OHP level, but DHEA-S helps characterize the androgen profile [11].

Adrenal tumors become the primary concern when DHEA-S exceeds 600-700 mcg/dL, especially in postmenopausal women or when levels rise rapidly. DHEA-S above 700 mcg/dL strongly suggests an adrenal neoplasm, and values exceeding 800 mcg/dL warrant urgent imaging with CT or MRI [12]. Adrenocortical carcinomas frequently secrete DHEA-S, and the test is used both for diagnosis and for monitoring recurrence after resection.

Dr. Richard Auchus, a leading adrenal steroid researcher at the University of Michigan, has noted: "DHEA-S is the single best screening test for adrenal androgen excess because of its long half-life and exclusive adrenal origin" [13].

What Low DHEA-S Levels Indicate

Low DHEA-S may reflect adrenal insufficiency, hypopituitarism, or the expected decline of aging.

Primary adrenal insufficiency (Addison's disease) causes low DHEA-S alongside low cortisol and aldosterone. However, clinicians do not use DHEA-S as a diagnostic test for Addison's. The ACTH stimulation test remains the standard [14]. Once diagnosed, some endocrinologists prescribe DHEA replacement (25-50 mg daily) for women with adrenal insufficiency who report persistent fatigue, low mood, or decreased libido despite adequate glucocorticoid and mineralocorticoid replacement. A randomized controlled trial of 106 women with Addison's disease found that 50 mg DHEA daily for 12 months improved well-being scores and sexual function compared to placebo [15].

Secondary adrenal insufficiency from pituitary disease or chronic glucocorticoid use also suppresses DHEA-S. Patients on long-term prednisone for autoimmune conditions commonly show DHEA-S levels 40-60% below age-matched norms [14].

Age-related decline is universal. The cross-sectional data from the Baltimore Longitudinal Study of Aging confirmed that DHEA-S decreases approximately 2-5% per year after peak levels in the mid-20s, a steeper percentage decline than any other adrenal steroid [7].

The clinical meaning of age-related low DHEA-S remains debated. Some observational studies have linked low DHEA-S to increased cardiovascular mortality in men. A prospective study of 963 men (mean age 71) published in the New England Journal of Medicine found that men in the lowest quartile of DHEA-S had a significantly higher risk of death from cardiovascular disease over a 12-year follow-up (relative risk 1.36 to 95% CI 1.05-1.76) [16]. Whether supplementation changes that risk has not been demonstrated in randomized trials.

How to Raise DHEA-S Levels

Several strategies can influence DHEA-S, though the evidence quality varies.

DHEA supplementation is the most direct approach. Over-the-counter DHEA is available in the United States as a dietary supplement (typically 25-50 mg daily). A 2006 randomized trial (N=280) published in the New England Journal of Medicine gave 50 mg DHEA daily to elderly men and women for two years. Serum DHEA-S levels rose to concentrations typical of young adults within two weeks. The study found no significant improvement in body composition, physical performance, insulin sensitivity, or quality of life compared to placebo [17]. The American Association of Clinical Endocrinology (AACE) has not endorsed routine DHEA supplementation for aging.

For women with adrenal insufficiency specifically, the Endocrine Society's 2016 guideline states: "A trial of DHEA replacement may be considered in women with adrenal insufficiency and low libido, depressed mood, or low energy, despite optimized glucocorticoid and mineralocorticoid replacement" [14].

Exercise modestly increases DHEA-S. A 12-week resistance training program in postmenopausal women produced a 15% increase in DHEA-S [18]. Chronic endurance exercise has shown similar but smaller effects.

Stress reduction may help preserve DHEA-S by reducing chronic ACTH-cortisol axis dysregulation, though direct evidence linking mindfulness or sleep interventions to DHEA-S increases is limited.

Caloric adequacy matters. Severe caloric restriction and overtraining suppress the hypothalamic-pituitary-adrenal axis and can lower DHEA-S, especially in female athletes with relative energy deficiency in sport (RED-S) [19].

How to Lower DHEA-S Levels

Lowering DHEA-S is typically necessary only when the elevation reflects an underlying condition causing unwanted androgen effects.

Combined oral contraceptives (COCs) reduce DHEA-S by 30-60% in women with PCOS or idiopathic hyperandrogenism. The estrogen component increases sex hormone-binding globulin (SHBG) while the progestin suppresses adrenal androgen output [10]. Pills containing anti-androgenic progestins (drospirenone, cyproterone acetate) may offer additional benefit for acne and hirsutism.

Glucocorticoid therapy in low doses (dexamethasone 0.25-0.5 mg at bedtime, or prednisone 2.5-5 mg daily) suppresses ACTH-driven adrenal androgen production. This approach is used primarily in non-classic congenital adrenal hyperplasia [11]. The goal is to normalize DHEA-S and reduce androgen-mediated symptoms without inducing Cushingoid side effects.

Insulin-sensitizing agents like metformin have shown inconsistent effects on DHEA-S specifically, though they lower total and free testosterone in women with PCOS [20]. Metformin's primary mechanism targets ovarian rather than adrenal androgen synthesis.

Lifestyle interventions for insulin resistance, including weight loss of 5-10% of body weight, can reduce DHEA-S modestly in women with PCOS. The mechanism likely involves improved insulin sensitivity, since hyperinsulinemia may stimulate adrenal androgen production through insulin receptor signaling in the zona reticularis [9].

For adrenal tumors causing markedly elevated DHEA-S, surgical resection is the definitive treatment. Post-operative DHEA-S monitoring helps detect recurrence [12].

When Clinicians Order a DHEA-S Test

A DHEA-S test is not part of routine health screening. Clinicians order it in specific clinical scenarios.

Androgen excess evaluation in women is the most common indication. The 2023 international PCOS guideline recommends measuring DHEA-S, total testosterone, and free testosterone (or calculated free testosterone) when evaluating biochemical hyperandrogenism [10]. This helps differentiate adrenal from ovarian androgen sources.

Virilization workup is urgent. Rapid-onset deepening of the voice, male-pattern baldness, clitoromegaly, or marked increase in muscle mass in a woman warrants immediate DHEA-S testing to rule out an androgen-secreting adrenal tumor [4].

Adrenal insufficiency assessment sometimes includes DHEA-S. While the ACTH stimulation test is the primary diagnostic tool, a very low DHEA-S supports the diagnosis and helps guide replacement therapy decisions in women [14].

Premature adrenarche evaluation in children. When a child under 8 develops pubic hair, axillary hair, or body odor without breast development or testicular enlargement, DHEA-S helps confirm whether adrenal androgen production has started early. A DHEA-S above the prepubertal range confirms premature adrenarche, which is usually benign but requires follow-up [5].

Aging and wellness panels increasingly include DHEA-S. While age-related decline is normal and routine supplementation is not supported by guidelines, some clinicians track DHEA-S as part of a broader hormonal assessment in patients presenting with fatigue, low libido, or cognitive complaints.

How the Test Is Performed

A DHEA-S test requires a simple venous blood draw. No fasting is required, and the sample can be collected at any time of day because DHEA-S shows minimal diurnal variation [2]. This is a practical advantage over cortisol, which must be measured in the early morning or via 24-hour urine.

Results are typically reported in micrograms per deciliter (mcg/dL) or micromoles per liter (mcmol/L). Turnaround time is 1-3 business days at most commercial laboratories.

Biotin supplementation (common in hair and nail vitamins) can interfere with immunoassay-based DHEA-S measurements, potentially producing falsely high or low results. The FDA issued a safety communication in 2017 warning that high-dose biotin (>5 mg/day) may affect streptavidin-biotin-based assays, which include some DHEA-S platforms [21]. Patients should stop biotin at least 72 hours before testing.

Oral DHEA supplements will raise DHEA-S levels within hours of ingestion and should be withheld on the day of testing if the goal is to assess endogenous production [17].